Jaszberenyi M, Thurzo B, Jayakumar A, Schally A
Int J Mol Sci. 2024; 25(23).
PMID: 39684795
PMC: 11641508.
DOI: 10.3390/ijms252313086.
Li L, Nguyen A, Zhao B, Vest R, Yerra L, Sun B
Neurotrauma Rep. 2024; 5(1):1016-1026.
PMID: 39464529
PMC: 11499285.
DOI: 10.1089/neur.2024.0060.
Sridharan P, Koh Y, Miller E, Hu D, Chakraborty S, Tripathi S
Cell Rep Med. 2024; 5(9):101715.
PMID: 39241772
PMC: 11525032.
DOI: 10.1016/j.xcrm.2024.101715.
Mann G, Daksh S, Kumar N, Kaul A, Roy B, Thirumal M
J Biol Inorg Chem. 2024; 29(2):187-199.
PMID: 38607392
DOI: 10.1007/s00775-024-02049-x.
Jankovic T, Pilipovic K
Exp Neurobiol. 2023; 32(4):195-215.
PMID: 37749924
PMC: 10569144.
DOI: 10.5607/en23008.
Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment.
Nozari A, Sharma A, Wang Z, Feng L, Muresanu D, Tian Z
Adv Neurobiol. 2023; 32:271-313.
PMID: 37480464
DOI: 10.1007/978-3-031-32997-5_7.
An exhaustive analysis of post-traumatic brain injury dementia using bibliometric methodologies.
Sang X, Wang C, Chen W, Rong H, Hou L
Front Neurol. 2023; 14:1165059.
PMID: 37456644
PMC: 10345842.
DOI: 10.3389/fneur.2023.1165059.
Immunocal® limits gliosis in mouse models of repetitive mild-moderate traumatic brain injury.
Koza L, Pena C, Russell M, Smith A, Molnar J, Devine M
Brain Res. 2023; 1808:148338.
PMID: 36966959
PMC: 10258892.
DOI: 10.1016/j.brainres.2023.148338.
Mathematical model of mechanobiology of acute and repeated synaptic injury and systemic biomarker kinetics.
Gharahi H, Garimella H, Chen Z, Gupta R, Przekwas A
Front Cell Neurosci. 2023; 17:1007062.
PMID: 36814869
PMC: 9939777.
DOI: 10.3389/fncel.2023.1007062.
Combination of a Chaperone Synthesis Inducer and an Inhibitor of GAPDH Aggregation for Rehabilitation after Traumatic Brain Injury: A Pilot Study.
Dutysheva E, Mikhaylova E, Trestsova M, Andreev A, Apushkin D, Utepova I
Pharmaceutics. 2023; 15(1).
PMID: 36678636
PMC: 9867013.
DOI: 10.3390/pharmaceutics15010007.
Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases.
Ganne A, Balasubramaniam M, Mainali N, Atluri P, Shmookler Reis R, Ayyadevara S
Int J Mol Sci. 2022; 23(24).
PMID: 36555098
PMC: 9779020.
DOI: 10.3390/ijms232415457.
Nanoparticle-based drug delivery for the treatment of traumatic brain injury.
Mohammed F, Omay S, Sheth K, Zhou J
Expert Opin Drug Deliv. 2022; 20(1):55-73.
PMID: 36420918
PMC: 9983310.
DOI: 10.1080/17425247.2023.2152001.
Traumatic Brain Injury Biomarkers, Simulations and Kinetics.
Hicks C, Dhiman A, Barrymore C, Goswami T
Bioengineering (Basel). 2022; 9(11).
PMID: 36354523
PMC: 9687153.
DOI: 10.3390/bioengineering9110612.
Exosomes as CNS Drug Delivery Tools and Their Applications.
Sun K, Zheng X, Jin H, Yu F, Zhao W
Pharmaceutics. 2022; 14(10).
PMID: 36297688
PMC: 9609403.
DOI: 10.3390/pharmaceutics14102252.
The evolving role of extracellular vesicles (exosomes) as biomarkers in traumatic brain injury: Clinical perspectives and therapeutic implications.
Khan N, Asim M, El-Menyar A, Biswas K, Rizoli S, Al-Thani H
Front Aging Neurosci. 2022; 14:933434.
PMID: 36275010
PMC: 9584168.
DOI: 10.3389/fnagi.2022.933434.
The heterogeneity of microglial activation and its epigenetic and non-coding RNA regulations in the immunopathogenesis of neurodegenerative diseases.
Li C, Ren J, Zhang M, Wang H, Yi F, Wu J
Cell Mol Life Sci. 2022; 79(10):511.
PMID: 36066650
PMC: 11803019.
DOI: 10.1007/s00018-022-04536-3.
Uncovering temporospatial sensitive TBI targeting strategies via in vivo phage display.
Martinez B, Mousa G, Fleck K, MacCulloch T, Diehnelt C, Stephanopoulos N
Sci Adv. 2022; 8(29):eabo5047.
PMID: 35867794
PMC: 9307250.
DOI: 10.1126/sciadv.abo5047.
Bio-Evaluation of Tc-Labeled Homodimeric Chalcone Derivative as Amyloid-β-Targeting Probe.
Mann G, Chauhan K, Kumar V, Daksh S, Kumar N, Thirumal M
Front Med (Lausanne). 2022; 9:813465.
PMID: 35783620
PMC: 9249127.
DOI: 10.3389/fmed.2022.813465.
Transgenic Mouse Models of Alzheimer's Disease: An Integrative Analysis.
Sanchez-Varo R, Mejias-Ortega M, Fernandez-Valenzuela J, Nunez-Diaz C, Caceres-Palomo L, Vegas-Gomez L
Int J Mol Sci. 2022; 23(10).
PMID: 35628216
PMC: 9142061.
DOI: 10.3390/ijms23105404.
Traumatic brain injury and the development of parkinsonism: Understanding pathophysiology, animal models, and therapeutic targets.
Padmakumar S, Kulkarni P, Ferris C, Bleier B, Amiji M
Biomed Pharmacother. 2022; 149:112812.
PMID: 35290887
PMC: 9050934.
DOI: 10.1016/j.biopha.2022.112812.